USV Launches Concordance Tool to Strengthen Gestational Diabetes Care in India

USV, an Indian multinational healthcare company and holds the 1st position by prescriptions in the Oral Anti-Diabetic and Cardiology markets, has
introduced a first-of-its-kind Concordance
Tool for Gestational Diabetes Mellitus (GDM).

This initiative
aims to improve short-term pregnancy outcomes and support long-term health in
women affected by GDM.

GDM affects up to 14% of pregnancies
in India, with prevalence rising to nearly 18% in urban areas. Left unmanaged,
it can result in serious complications for both mother and child, while
significantly increasing the mother’s risk of developing type 2 diabetes,
cardiovascular disease, and certain cancers. These risks can also carry over to
the next generation, fueling a cycle of chronic illness¹.

The Concordance Tool is a structured,
visual aid designed for gynecologists, obstetricians, and expecting
mothers—especially in high-volume clinical settings. It enables users to:

• Understand GDM and its risks
• Emphasize early screening and
  lifestyle interventions

• Support shared decision-making and
  treatment adherence

• Reinforce postpartum follow-up to
  prevent progression to type 2 diabetes

Research shows that 70–85% of GDM
cases² can be effectively managed through
timely diagnosis, nutrition therapy, and weight management.

This tool represents a meaningful
shift from reactive care to proactive prevention- ensuring healthier futures for
both mothers and their children.

To request the Concordance Tool,
please fill out the form here: https://forms.gle/XsZKexheCxwEm4nc9

About USV: Established in 1961, USV Private
Limited is a leading Indian multinational healthcare company with a presence in
65+ countries. In India, USV holds the #1 position by prescriptions in the Oral
Anti-Diabetic and Cardiology markets. Its global portfolio includes APIs,
generics, branded generics, peptides, and biosimilars.

References:

• Vinoth N, Jaget N, Sekar
  SG, Priyanka R. A study on prevalence of gestational diabetes mellitus and its
  associated risk indicators in pregnant women attending antenatal clinic in a
  tertiary health centre. Int J Reprod Contracept Obstet Gynecol 2023;12:1374-8.
• Rasmussen L, Poulsen CW, Kampmann U, Smedegaard SB, Ovesen PG,
  Fuglsang J. Diet and Healthy Lifestyle in the Management of Gestational
  Diabetes Mellitus. Nutrients. 2020 Oct 6;12(10):3050. doi: 10.3390/nu12103050.
  PMID: 33036170; PMCID: PMC7599681.